Everence Capital Management »

Arcus Biosciences Incorporated shares owned by Everence Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Everence Capital Management from 13F filings

Historical chart of Everence Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Everence Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Everence Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $190k 10k 18.89
2023-12-31 $192k 10k 19.09
2023-09-30 $181k 10k 17.99
2023-06-30 $207k 10k 20.58
2023-03-31 $183k 10k 18.19
2022-12-31 $208k 10k 20.68
2022-09-30 $263k 10k 26.14
2022-06-30 $255k 10k 25.35

More positions owned by Everence Capital Management

Praxis Impact Bond I Eqty (MIIIX)
Apple Eqty (AAPL)
Microsoft Corporation Eqty (MSFT)
Nvidia Corp Eqty (NVDA)
Praxis Intl Index I Eqty (MPLIX)
Praxis Value Index I Eqty (MVIIX)
Praxis Growth Index I Eqty (MMDEX)
Amazoncom Eqty (AMZN)
Meta Platforms Inc Cl A Eqty (META)
Praxis Small Cap Index I Eqty (MMSIX)
Alphabet Inc Class A Eqty (GOOGL)
Alphabet Inc Class C Eqty (GOOG)
ELI LILLY and Eqty (LLY)
JPMORGAN CHASE and Eqty (JPM)
Broadcom Eqty (AVGO)

View all positions for Everence Capital Management

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Dimensional Fund Advisors
Invus Financial Advisors
Boxer Capital
Alliancebernstein
Decheng Capital
Point72 Asset Management
Bnp Paribas Investment Partners
Goldman Sachs Group
Balyasny Asset Management
Susquehanna International
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital

View all funds holding Arcus Biosciences Incorporated